Cancel anytime
BIO-Key International Inc (BKYI)BKYI
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/16/2024: BKYI (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Profit: -32.18% | Upturn Advisory Performance 1 | Avg. Invested days: 11 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 08/16/2024 |
Type: Stock | Today’s Advisory: PASS |
Profit: -32.18% | Avg. Invested days: 11 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 08/16/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 2.64M USD |
Price to earnings Ratio - | 1Y Target Price 3 |
Dividends yield (FY) - | Basic EPS (TTM) -8.8 |
Volume (30-day avg) 11812 | Beta 0.31 |
52 Weeks Range 1.00 - 10.57 | Updated Date 09/17/2024 |
Company Size Small-Cap Stock | Market Capitalization 2.64M USD | Price to earnings Ratio - | 1Y Target Price 3 |
Dividends yield (FY) - | Basic EPS (TTM) -8.8 | Volume (30-day avg) 11812 | Beta 0.31 |
52 Weeks Range 1.00 - 10.57 | Updated Date 09/17/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -91.72% | Operating Margin (TTM) -144.93% |
Management Effectiveness
Return on Assets (TTM) -55.68% | Return on Equity (TTM) -458.11% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 3645895 | Price to Sales(TTM) 0.38 |
Enterprise Value to Revenue 0.52 | Enterprise Value to EBITDA -0.74 |
Shares Outstanding 1982200 | Shares Floating 1590518 |
Percent Insiders 8.53 | Percent Institutions 8.5 |
Trailing PE - | Forward PE - | Enterprise Value 3645895 | Price to Sales(TTM) 0.38 |
Enterprise Value to Revenue 0.52 | Enterprise Value to EBITDA -0.74 | Shares Outstanding 1982200 | Shares Floating 1590518 |
Percent Insiders 8.53 | Percent Institutions 8.5 |
Analyst Ratings
Rating 4 | Target Price 2 | Buy 1 |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating 4 | Target Price 2 | Buy 1 | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
BIO-Key International Inc.: A Comprehensive Overview
Company Profile:
History and Background:
BIO-Key International Inc. (NASDAQ: BKYI) was founded in 1984 as a cybersecurity software and hardware company. It offers advanced biometric security solutions, including fingerprint, iris, and palm vein recognition, as well as hardware authentication devices. The company initially focused on developing hardware-based security solutions but has expanded to offer software solutions compatible with various platforms and devices.
Core Business Areas:
BIO-Key International operates in two primary business segments:
- Biometric Security Solutions: This segment offers fingerprint, iris, and palm vein recognition software and hardware for access control, identity management, and transaction security.
- Hardware Authentication Devices: This segment designs and manufactures USB tokens, smart cards, and fingerprint scanners for secure authentication.
Leadership Team and Corporate Structure:
BIO-Key International's leadership team includes:
- Mike DePasquale: Chairman and CEO
- Stephen Schuckenbrock: Chief Financial Officer
- Kevin Russell: Chief Technology Officer
- David C. Thomas: Chief Revenue Officer
The company's corporate structure is relatively straightforward, with a lean management team and centralized operations.
Top Products and Market Share:
Top Products:
- PortalGuard: A cloud-based biometric access control platform for single sign-on and multi-factor authentication.
- ID Sentry: A desktop application for multi-factor authentication and password management.
- WebID: A browser extension for secure access to web applications.
- Hardware Authentication Devices: USB tokens, smart cards, and fingerprint scanners used for two-factor authentication.
Market Share:
BIO-Key International competes in a fragmented market with several established players. The company does not disclose its market share publicly. However, industry reports suggest that BIO-Key holds a relatively small share of the global biometric market, estimated to be around 0.5%.
Product Performance and Market Reception:
BIO-Key's products have received generally positive reviews for their ease of use, security features, and compatibility with various platforms and devices. However, some users have reported issues with occasional software glitches and limited customer support.
Total Addressable Market:
The global biometric market is expected to reach $41.6 billion by 2027, growing at a CAGR of 17.7%. The US market is estimated to be worth approximately $10 billion.
Financial Performance:
Recent Financial Statements:
- Revenue: $2.8 million in 2022
- Net Income: -$12.1 million in 2022
- Profit Margin: -432% in 2022
- Earnings per Share (EPS): -$0.38 in 2022
Year-over-Year Performance:
BIO-Key International's financial performance has been volatile in recent years, with fluctuating revenue and significant losses.
Cash Flow and Balance Sheet:
BIO-Key International has a limited cash balance and a weak balance sheet. The company has been relying on debt financing to cover operating expenses and investments.
Dividends and Shareholder Returns:
BIO-Key International does not currently pay dividends and has not in the past. The company's stock has performed poorly in recent years, with a total return of -94% over the past five years.
Growth Trajectory:
Historical Growth:
BIO-Key International has experienced sluggish growth in recent years. Revenue has remained relatively stagnant, and the company has incurred significant losses.
Future Growth Projections:
BIO-Key International's future growth prospects are uncertain. The company aims to expand its product portfolio, enter new markets, and secure strategic partnerships to drive growth. However, achieving profitability remains a significant challenge.
Market Dynamics:
Industry Trends:
The biometric market is experiencing rapid growth, driven by increasing demand for secure authentication solutions in various sectors, including government, finance, healthcare, and enterprise.
Demand-Supply Scenario:
The demand for biometric solutions is outpacing the supply of qualified vendors, creating opportunities for companies like BIO-Key International to gain market share.
Technological Advancements:
Continued advancements in biometric technology, such as the development of more accurate and efficient sensors and algorithms, are driving market growth.
Company Positioning:
BIO-Key International is a relatively small player in the biometric market, facing stiff competition from established players with larger resources and wider product offerings. The company needs to differentiate itself through innovation, strategic partnerships, and cost-effective solutions.
Competitors:
Key competitors include:
- HID Global (HID)
- ASSA ABLOY (ASSA B)
- 3M (MMM)
- Suprema (SUPM)
- Aware (AWRE)
Challenges and Opportunities:
Challenges:
- Limited financial resources
- Intense competition
- Scaling operations to meet growing demand
- Demonstrating profitability
Opportunities:
- Expanding into new markets
- Developing innovative biometric solutions
- Securing strategic partnerships
- Capitalizing on increasing demand for secure authentication solutions
AI-Based Fundamental Rating:
Based on an AI-based analysis of BIO-Key International's financials, market position, and future prospects, the company receives a rating of 5 out of 10. This rating indicates a moderate investment potential, with the company facing significant challenges but also possessing opportunities for growth.
Sources and Disclaimers:
This overview was compiled using information from the following sources:
- BIO-Key International Inc. website
- SEC filings
- Industry reports
- News articles
This information is provided for informational purposes only and should not be considered investment advice. Please consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About BIO-Key International Inc
Exchange | NASDAQ | Headquaters | Holmdel, NJ, United States |
IPO Launch date | 1997-02-14 | Chairman & CEO | Mr. Michael W. DePasquale |
Sector | Industrials | Website | https://www.bio-key.com |
Industry | Security & Protection Services | Full time employees | 43 |
Headquaters | Holmdel, NJ, United States | ||
Chairman & CEO | Mr. Michael W. DePasquale | ||
Website | https://www.bio-key.com | ||
Website | https://www.bio-key.com | ||
Full time employees | 43 |
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, services and cloud host, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.